At a glance
ClinicalIndex Comparison RecordN/ACompleted· 78 enrolled
Drug / intervention
PQ Bypass System for Femoropopliteal Bypassdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PQ Bypass Systems for Femoropopliteal Bypass II (PQB 4 FP II)
In Brief
A clinical study evaluating PQ Bypass System for Femoropopliteal Bypass for Peripheral Arterial Disease. Completed, enrolled 78 participants across 8 sites in 6 countries.
Detailed Summary
To assess the safety and performance of the PQ Bypass System to access, deliver guidewires and implant stent grafts for a percutaneous fem-pop bypass.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesChile, Germany, Italy, Latvia, New Zealand, Poland
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJan 2015
First PostedJun 2015
Primary CompletionSep 2018
Study CompletionJun 2020
TodayJul 2026
First PostedJun 15, 2015
Enrollment StartJan 1, 2015
Primary CompletionSep 1, 2018
Study CompletionJun 1, 2020
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 11.0 years ago
Interventions
PQ Bypass System for Femoropopliteal Bypassdevice
To access, deliver guidewires and implant stent grafts for a percutaneous fem-pop bypass.